January is Glaucoma Awareness Month, and if there’s one thing most eye doctors wish people understood better, it’s this: ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

OT dives into a key topic in the education programme at 100% Optical 2026. This week: Sana Hamid shares insight into her ...

A headache is a common occurrence for many of us, but for Effie Iemma , it was the first sign that she had glaucoma. "I had an eye test, just my normal routine eye test about six months earlier [but] ...

Glaucoma is a group of eye conditions that can cause vision loss and damage to the optic nerve. Possible treatments include eye drops and surgery. Glaucoma is relatively common. It is most likely to ...

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...

From artificial intelligence to home monitoring, Joel Schuman, MD, of Wills Eye Hospital, explores the innovations that could ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma ...

Eye floaters are not a sign of glaucoma, which typically causes gradual vision loss. Floaters are small dots or shapes that appear across a person’s vision. It is important to consult an eye doctor if ...